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Positive FilmArray results for respiratory tract microbiologic characterization in







No. of patients 53 10
Age (years) (±SD) 62.4 ± 18 63.3 ± 18
Sex (F/M) 25/28 4/6
No. of nasopharyngeal swabs 40 8
No. of other type of specimens 13a 2b
No. of pathogens detected
Staphylococcus aureus 18 7
Moraxella catarrhalis 7 1
Haemophilus influenzae 13 2
Streptococcus agalactiae 5 1
Mycoplasma pneumoniae 4 d
Streptococcus pneumoniae 3 d
Streptococcus pyogenes 3 d
Pseudomonas aeruginosa 2 d
Enterobacter cloacae 3 1
Klebsiella oxytoca 1 d
Klebsiella pneumoniae 4 1
Escherichia coli 3 1
Adenovirus 1 d
Influenza virus B 4 d
Influenza virus A 5 d
RSV 2 dAs a result of the clinical similarity of coronavirus disease 2019
(COVID-19) with other flulike syndromes, patients were tested for
other pathogens of respiratory tract infections as well, especially in
the first weeks of the epidemic. In those weeks, we used the
multiplex PCR BioFire FilmArray Pneumonia panel (BioFire Di-
agnostics; bioMerieux, Marcy l’Etoile, France), allowing the detec-
tion of 33 respiratory pathogens with a run time of 1 hour. Here we
report the aetiologic pattern of respiratory tract infections diag-
nosed at the Amedeo di Savoia Hospital, the regional reference
centre for infectious diseases of Piedmont, north-western Italy,
during the first weeks of the COVID-19 epidemic.
We retrospectively reviewed clinical and microbiologic records
generated via routine clinical practice (ethical approval not
required) from 162 consecutive patients (93 male; median age,
64 years; range, 12e93 years) from 12 February to 31 March 2020
with respiratory symptoms whowere screened with FilmArray and
real-time reverse transcriptase PCR for COVID-19 diagnosis after
multiple sample collection in Copan UTM transport medium
(Copan, Brescia, Italy). For the detection of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) specific RNA, a multiplex
Real Time PCR Kit (Liferiver, San Diego, CA, USA) was used (detec-
tion limit, 1  103 copies/mL). The kit measures three virus genes
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Scientific, Waltham, MA, USA) [1]. The results of the two tests were
compared by the chi-square test.
We included nasopharyngeal swab (123/162, 75.9%), bron-
choalveolar lavage (17/162, 10.5%), bronchoaspirate (12/162, 7.4%)
and sputum (10/162, 6.2%) samples. SARS-CoV-2 RNAwas detected
in 56 (34.6%) of 162 samples, while FilmArray showed the presence
of viruses and/or bacteria in 63 (38.9%) of 162. FilmArray results (28Rhinovirus/enterovirus 4 d
Coronavirus (OC43, NL63, 229E) 4 d
Metapneumovirus 3 d
Total pathogens 89 14
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a Sputum (n ¼ 6), bronchoalveolar lavage (n ¼ 4) and brochoaspirates (n ¼ 3).
b Bronchoaspirates (n ¼ 2).
ublished by Elsevier Ltd. All rights reserved.
Fig. 1. Prevalence of positive samples by date. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
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(84.1%) of 63 patients and viruses in 22 (34.9%) of 63, as follows:
Staphylococcus aureus (25/63, 39.7%), Haemophilus influenzae (15/
63, 23.8%), group B streptococci (6/63, 9.5%), influenza Avirus (5/63,
7.9%) and influenza B, coronaviruses and rhinoviruses/enterovi-
ruses (each 4/63, 6.3%).
FilmArray results were positive in 10 of 56 SARS-CoV-
2einfected patients (17.8% vs. 50% in SARS-CoV-2enegative sam-
ples, c2 ¼ 15.9, p <0.001); interestingly, no other virus was found in
SARS-CoV-2epositive patients (0 vs. 20.7%, c2¼13.4, p <0.001), but
only Staphylococcus aureus (7/10), Haemophilus influenzae (2/10),
Escherichia coli (2/10), Moraxella catarrhalis, group B streptococci,
Klebsiella pneumoniae and Enterobacter cloacae (1/10 each), most
probably as a result of colonization or bacterial superinfection in
two COVID-19 patients whose bronchoaspirate tested positive for
Haemophilus influenzae plus Escherichia coli and Staphylococcus
aureus, respectively (Table 1). Soon after the onset of the global
SARS-CoV-2 epidemic, the presence of other respiratory viruses
declined and even disappeared (Fig. 1).
Our data are consistent with the absence of other respiratory
virus coinfection in SARS-CoV-2 patients and a low bacterial coin-
fection rate mostly reflecting a carriage status.
Recently several articles have reported the possible concomi-
tant presence of respiratory pathogens in subjects with COVID-19.
Viral and bacterial pathogens have been described in case reports,
case series and four cohorts: a low prevalence was reported
(1.6e6.5%), with the exception of a single recent report (24/116,
20.7%) [2]. Phenomena like viral interference, common receptor
usage, different inoculum size or simply resource competition
might explain why dual or multiple concurrent viral respiratory
infections are rare [3,4]. Few articles have addressed the clinical
features of coinfected patients, with the relevant exception of a
child with SARS-CoV-2, metapneumovirus and respiratory syn-
cytial virus admitted to an intensive care unit, with no increased
risk of severe disease reported [5]. In line with this, a 9-year-old
child included in the French Alps cluster was coinfected with
SARS-CoV-2, rhinovirus/enterovirus and influenza H1N1 and
asymptomatic, but no secondary cases were found among his
contacts [6].In conclusion, a multiplex PCR system for the rapid diagnosis of
respiratory infections revealed that there is virtually no concomi-
tant infection in patients positive for SARS-CoV-2. In addition,
interestingly, with the spread of SARS-CoV-2, other respiratory
pathogens have seemed to vanish.Transparency declaration
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